Patents by Inventor Karine AGUERA

Karine AGUERA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD OF TREATING A MAMMAL, INCLUDING HUMAN, AGAINST CANCER USING METHIONINE AND ASPARAGINE DEPLETION
    Publication number: 20220040272
    Abstract: The invention is related to a new method for treating liquid and solid cancers, in a mammal, including human, wherein methioninase is administered before asparaginase. The invention also encompasses the use of a dietary methionine deprivation, possibly combined with methioninase administration, in advance of asparaginase treatment. Methioninase and asparaginase may be used in particular under free form, pegylated form or encapsulated into erythrocytes.
    Type: Application
    Filed: August 24, 2021
    Publication date: February 10, 2022
    Inventors: Karine AGUERA, Willy BERLIER, Fabien GAY, Yann GODFRIN
  • Method of treating a mammal, including human, against cancer using methionine and asparagine depletion
    Patent number: 11141468
    Abstract: The invention is related to a new method for treating liquid and solid cancers, in a mammal, including human, wherein methioninase is administered before asparaginase. The invention also encompasses the use of a dietary methionine deprivation, possibly combined with methioninase administration, in advance of asparaginase treatment. Methioninase and asparaginase may be used in particular under free form, pegylated form or encapsulated into erythrocytes.
    Type: Grant
    Filed: January 2, 2017
    Date of Patent: October 12, 2021
    Assignee: ERYTECH PHARMA
    Inventors: Karine Aguera, Willy Berlier, Fabien Gay, Yann Godfrin
  • METHOD OF TREATING A MAMMAL, INCLUDING HUMAN, AGAINST CANCER USING METHIONINE AND ASPARAGINE DEPLETION
    Publication number: 20190000941
    Abstract: The invention is related to a new method for treating liquid and solid cancers, in a mammal, including human, wherein methioninase is administered before asparaginase. The invention also encompasses the use of a dietary methionine deprivation, possibly combined with methioninase administration, in advance of asparaginase treatment. Methioninase and asparaginase may be used in particular under free form, pegylated form or encapsulated into erythrocytes.
    Type: Application
    Filed: January 2, 2017
    Publication date: January 3, 2019
    Inventors: Karine AGUERA, Willy BERLIER, Fabien GAY, Yann GODFRIN